report cover

Onychomycosis Therapy Market, Global Outlook and Forecast 2023-2029

  • 21 April 2023
  • Life Sciences
  • 65 Pages
  • Report code : 24WT-7649989

Onychomycosis Therapy and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Onychomycosis Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Onychomycosis Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Onychomycosis Therapy Overall Market Size
2.1 Global Onychomycosis Therapy Market Size: 2022 VS 2029
2.2 Global Onychomycosis Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Onychomycosis Therapy Players in Global Market
3.2 Top Global Onychomycosis Therapy Companies Ranked by Revenue
3.3 Global Onychomycosis Therapy Revenue by Companies
3.4 Top 3 and Top 5 Onychomycosis Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Onychomycosis Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Onychomycosis Therapy Players in Global Market
3.6.1 List of Global Tier 1 Onychomycosis Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Onychomycosis Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Onychomycosis Therapy Market Size Markets, 2022 & 2029
4.1.2 Drug Therapy
4.1.3 Laser Therapy
4.1.4 Photodynamic Therapy
4.2 By Type - Global Onychomycosis Therapy Revenue & Forecasts
4.2.1 By Type - Global Onychomycosis Therapy Revenue, 2018-2023
4.2.2 By Type - Global Onychomycosis Therapy Revenue, 2024-2029
4.2.3 By Type - Global Onychomycosis Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Onychomycosis Therapy Market Size, 2022 & 2029
5.1.2 General Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Onychomycosis Therapy Revenue & Forecasts
5.2.1 By Application - Global Onychomycosis Therapy Revenue, 2018-2023
5.2.2 By Application - Global Onychomycosis Therapy Revenue, 2024-2029
5.2.3 By Application - Global Onychomycosis Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Onychomycosis Therapy Market Size, 2022 & 2029
6.2 By Region - Global Onychomycosis Therapy Revenue & Forecasts
6.2.1 By Region - Global Onychomycosis Therapy Revenue, 2018-2023
6.2.2 By Region - Global Onychomycosis Therapy Revenue, 2024-2029
6.2.3 By Region - Global Onychomycosis Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Onychomycosis Therapy Revenue, 2018-2029
6.3.2 US Onychomycosis Therapy Market Size, 2018-2029
6.3.3 Canada Onychomycosis Therapy Market Size, 2018-2029
6.3.4 Mexico Onychomycosis Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Onychomycosis Therapy Revenue, 2018-2029
6.4.2 Germany Onychomycosis Therapy Market Size, 2018-2029
6.4.3 France Onychomycosis Therapy Market Size, 2018-2029
6.4.4 U.K. Onychomycosis Therapy Market Size, 2018-2029
6.4.5 Italy Onychomycosis Therapy Market Size, 2018-2029
6.4.6 Russia Onychomycosis Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Onychomycosis Therapy Market Size, 2018-2029
6.4.8 Benelux Onychomycosis Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Onychomycosis Therapy Revenue, 2018-2029
6.5.2 China Onychomycosis Therapy Market Size, 2018-2029
6.5.3 Japan Onychomycosis Therapy Market Size, 2018-2029
6.5.4 South Korea Onychomycosis Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Onychomycosis Therapy Market Size, 2018-2029
6.5.6 India Onychomycosis Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Onychomycosis Therapy Revenue, 2018-2029
6.6.2 Brazil Onychomycosis Therapy Market Size, 2018-2029
6.6.3 Argentina Onychomycosis Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Onychomycosis Therapy Revenue, 2018-2029
6.7.2 Turkey Onychomycosis Therapy Market Size, 2018-2029
6.7.3 Israel Onychomycosis Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Onychomycosis Therapy Market Size, 2018-2029
6.7.5 UAE Onychomycosis Therapy Market Size, 2018-2029
7 Onychomycosis Therapy Companies Profiles
7.1 Bausch Health
7.1.1 Bausch Health Company Summary
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Onychomycosis Therapy Major Product Offerings
7.1.4 Bausch Health Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.1.5 Bausch Health Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Onychomycosis Therapy Major Product Offerings
7.2.4 Bayer Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Cipla
7.3.1 Cipla Company Summary
7.3.2 Cipla Business Overview
7.3.3 Cipla Onychomycosis Therapy Major Product Offerings
7.3.4 Cipla Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.3.5 Cipla Key News & Latest Developments
7.4 Dr Reddys Laboratories
7.4.1 Dr Reddys Laboratories Company Summary
7.4.2 Dr Reddys Laboratories Business Overview
7.4.3 Dr Reddys Laboratories Onychomycosis Therapy Major Product Offerings
7.4.4 Dr Reddys Laboratories Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.4.5 Dr Reddys Laboratories Key News & Latest Developments
7.5 Galderma
7.5.1 Galderma Company Summary
7.5.2 Galderma Business Overview
7.5.3 Galderma Onychomycosis Therapy Major Product Offerings
7.5.4 Galderma Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.5.5 Galderma Key News & Latest Developments
7.6 Johnson and Johnson
7.6.1 Johnson and Johnson Company Summary
7.6.2 Johnson and Johnson Business Overview
7.6.3 Johnson and Johnson Onychomycosis Therapy Major Product Offerings
7.6.4 Johnson and Johnson Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.6.5 Johnson and Johnson Key News & Latest Developments
7.7 Lumenis
7.7.1 Lumenis Company Summary
7.7.2 Lumenis Business Overview
7.7.3 Lumenis Onychomycosis Therapy Major Product Offerings
7.7.4 Lumenis Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.7.5 Lumenis Key News & Latest Developments
7.8 Medimetriks
7.8.1 Medimetriks Company Summary
7.8.2 Medimetriks Business Overview
7.8.3 Medimetriks Onychomycosis Therapy Major Product Offerings
7.8.4 Medimetriks Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.8.5 Medimetriks Key News & Latest Developments
7.9 Moberg Pharma
7.9.1 Moberg Pharma Company Summary
7.9.2 Moberg Pharma Business Overview
7.9.3 Moberg Pharma Onychomycosis Therapy Major Product Offerings
7.9.4 Moberg Pharma Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.9.5 Moberg Pharma Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Onychomycosis Therapy Major Product Offerings
7.10.4 Novartis Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Pfizer
7.11.1 Pfizer Company Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Onychomycosis Therapy Major Product Offerings
7.11.4 Pfizer Onychomycosis Therapy Revenue in Global Market (2018-2023)
7.11.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Onychomycosis Therapy Market Opportunities & Trends in Global Market
Table 2. Onychomycosis Therapy Market Drivers in Global Market
Table 3. Onychomycosis Therapy Market Restraints in Global Market
Table 4. Key Players of Onychomycosis Therapy in Global Market
Table 5. Top Onychomycosis Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Onychomycosis Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Onychomycosis Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Onychomycosis Therapy Product Type
Table 9. List of Global Tier 1 Onychomycosis Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Onychomycosis Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Onychomycosis Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Onychomycosis Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Onychomycosis Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Onychomycosis Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Onychomycosis Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Onychomycosis Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Onychomycosis Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Onychomycosis Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Onychomycosis Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Onychomycosis Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Onychomycosis Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Onychomycosis Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Onychomycosis Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Onychomycosis Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Onychomycosis Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Onychomycosis Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Onychomycosis Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Onychomycosis Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Onychomycosis Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Bausch Health Company Summary
Table 31. Bausch Health Onychomycosis Therapy Product Offerings
Table 32. Bausch Health Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Bausch Health Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Onychomycosis Therapy Product Offerings
Table 36. Bayer Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Cipla Company Summary
Table 39. Cipla Onychomycosis Therapy Product Offerings
Table 40. Cipla Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Cipla Key News & Latest Developments
Table 42. Dr Reddys Laboratories Company Summary
Table 43. Dr Reddys Laboratories Onychomycosis Therapy Product Offerings
Table 44. Dr Reddys Laboratories Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Dr Reddys Laboratories Key News & Latest Developments
Table 46. Galderma Company Summary
Table 47. Galderma Onychomycosis Therapy Product Offerings
Table 48. Galderma Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Galderma Key News & Latest Developments
Table 50. Johnson and Johnson Company Summary
Table 51. Johnson and Johnson Onychomycosis Therapy Product Offerings
Table 52. Johnson and Johnson Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson and Johnson Key News & Latest Developments
Table 54. Lumenis Company Summary
Table 55. Lumenis Onychomycosis Therapy Product Offerings
Table 56. Lumenis Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Lumenis Key News & Latest Developments
Table 58. Medimetriks Company Summary
Table 59. Medimetriks Onychomycosis Therapy Product Offerings
Table 60. Medimetriks Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Medimetriks Key News & Latest Developments
Table 62. Moberg Pharma Company Summary
Table 63. Moberg Pharma Onychomycosis Therapy Product Offerings
Table 64. Moberg Pharma Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Moberg Pharma Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Onychomycosis Therapy Product Offerings
Table 68. Novartis Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Onychomycosis Therapy Product Offerings
Table 72. Pfizer Onychomycosis Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Pfizer Key News & Latest Developments
List of Figures
Figure 1. Onychomycosis Therapy Segment by Type in 2022
Figure 2. Onychomycosis Therapy Segment by Application in 2022
Figure 3. Global Onychomycosis Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Onychomycosis Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Onychomycosis Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Onychomycosis Therapy Revenue in 2022
Figure 8. By Type - Global Onychomycosis Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Onychomycosis Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Onychomycosis Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Onychomycosis Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Onychomycosis Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Onychomycosis Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Onychomycosis Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Onychomycosis Therapy Revenue Market Share, 2018-2029
Figure 16. US Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Onychomycosis Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Onychomycosis Therapy Revenue Market Share, 2018-2029
Figure 28. China Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Onychomycosis Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Onychomycosis Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Onychomycosis Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Bausch Health Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Cipla Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Dr Reddys Laboratories Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Galderma Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson and Johnson Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Lumenis Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Medimetriks Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Moberg Pharma Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Novartis Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Pfizer Onychomycosis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Onychomycosis Therapy and Forecast Market

Leave This Empty: